Marshall Wace Portfolio holdings
AUM
$84.1B
1-Year Return
27.54%
This Quarter Return
+0.63%
1 Year Return
+27.54%
3 Year Return
+105.03%
5 Year Return
+179.94%
10 Year Return
+445.45%
AUM
$20.2B
AUM Growth
+$1.24B
(+6.5%)
Cap. Flow
+$1.34B
Cap. Flow
% of AUM
6.64%
Top 10 Holdings %
Top 10 Hldgs %
12.05%
Holding
3,463
New
955
Increased
736
Reduced
565
Closed
667
Top Buys
| 1 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$137M |
| 2 |
Uber
UBER
|
+$130M |
| 3 |
Canadian Pacific Kansas City
CP
|
+$112M |
| 4 |
The Beauty Health Co
SKIN
|
+$107M |
| 5 |
Dynavax Technologies
DVAX
|
+$98.3M |
Top Sells
| 1 |
PARA
Paramount Global Class B
PARA
|
+$181M |
| 2 |
Biogen
BIIB
|
+$181M |
| 3 |
Danaher
DHR
|
+$108M |
| 4 |
XYZ
Block, Inc.
XYZ
|
+$103M |
| 5 |
Aon
AON
|
+$100M |
Sector Composition
| 1 | Healthcare | 24.21% |
| 2 | Financials | 19.75% |
| 3 | Technology | 16.44% |
| 4 | Consumer Discretionary | 13.14% |
| 5 | Industrials | 5.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2251
Cardiff Oncology
CRDF
$136M
| $125K | ﹤0.01% |
18,769
-236,160
| -93% | -$1.57M |
|
2252
FlexShopper
FPAY
$18.5M
| $125K | ﹤0.01% |
+40,317
| New | +$125K |
|
2253
Fuel Tech
FTEK
$113M
| $124K | ﹤0.01% |
71,543
-48,318
| -40% | -$83.7K |
|
2254
Cerus
CERS
$236M
| $123K | ﹤0.01% |
+20,163
| New | +$123K |
|
|
XYF
2255
X Financial
XYF
$579M
| $123K | ﹤0.01% |
+29,681
| New | +$123K |
|
2256
TransAlta
TAC
$3.75B
| $121K | ﹤0.01% |
11,468
-227,149
| -95% | -$2.4M |
|
|
TRON
2257
DELISTED
Corner Growth Acquisition Corp. 2 Class A Ordinary Share
TRON
| $120K | ﹤0.01% |
+12,171
| New | +$120K |
|
2258
P3 Health Partners
PIII
$28.1M
| $119K | ﹤0.01% |
+240
| New | +$119K |
|
2259
ProPhase Labs
PRPH
$18M
| $119K | ﹤0.01% |
+22,801
| New | +$119K |
|
|
AXLA
2260
DELISTED
Axcella Health Inc. Common Stock
AXLA
| $119K | ﹤0.01% |
1,601
-1,296
| -45% | -$96.3K |
|
2261
Oxford Square Capital
OXSQ
$170M
| $117K | ﹤0.01% |
+28,791
| New | +$117K |
|
2262
Lyra Therapeutics
LYRA
$10.3M
| $114K | ﹤0.01% |
249
-137
| -35% | -$62.7K |
|
2263
Royalty Management
RMCO
$28.7M
| $114K | ﹤0.01% |
+11,524
| New | +$114K |
|
2264
China Automotive Systems
CAAS
$138M
| $113K | ﹤0.01% |
34,614
-117,089
| -77% | -$382K |
|
2265
GT Biopharma
GTBP
$2.86M
| $112K | ﹤0.01% |
553
-307
| -36% | -$62.2K |
|
2266
Ryvyl
RVYL
$9.53M
| $111K | ﹤0.01% |
+1,340
| New | +$111K |
|
|
VNTR
2267
DELISTED
Venator Materials PLC
VNTR
| $110K | ﹤0.01% |
+38,353
| New | +$110K |
|
|
AXDX
2268
DELISTED
Accelerate Diagnostics
AXDX
| $108K | ﹤0.01% |
+1,845
| New | +$108K |
|
|
ARAV
2269
DELISTED
Aravive, Inc. Common Stock
ARAV
| $106K | ﹤0.01% |
28,462
-162,958
| -85% | -$607K |
|
2270
Protara Therapeutics
TARA
$121M
| $105K | ﹤0.01% |
15,190
-2,279
| -13% | -$15.8K |
|
|
SIOX
2271
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $103K | ﹤0.01% |
+47,537
| New | +$103K |
|
|
REVEU
2272
DELISTED
Alpine Acquisition Corporation Unit
REVEU
| $102K | ﹤0.01% |
+10,064
| New | +$102K |
|
|
ALR
2273
DELISTED
AlerisLife Inc. Common Stock
ALR
| $102K | ﹤0.01% |
23,211
-39,650
| -63% | -$174K |
|
2274
Compugen
CGEN
$125M
| $100K | ﹤0.01% |
16,482
-80,387
| -83% | -$488K |
|
2275
Indaptus Therapeutics
INDP
$2.85M
| $100K | ﹤0.01% |
+456
| New | +$100K |
|